LENIVIA DIN 02561778
Status: Marketed
Holder: ZOETIS CANADA INC
Available to quote
Health Canada record
| Active ingredient(s) | IZENIVETMAB 0.5 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Mar-2026 |
|---|
| Current status date | 31-Mar-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IZENIVETMAB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02561786 | LENIVIA | ZOETIS CANADA INC | Solution | IZENIVETMAB 1 MG | Marketed |
| 02561794 | LENIVIA | ZOETIS CANADA INC | Solution | IZENIVETMAB 1.5 MG | Marketed |
| 02561816 | LENIVIA | ZOETIS CANADA INC | Solution | IZENIVETMAB 3 MG | Marketed |
| 02561808 | LENIVIA | ZOETIS CANADA INC | Solution | IZENIVETMAB 2 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 36149 | 2025-10-14 | New Drug Submission (NDS) | |
Request a quote for LENIVIA
How to read a Canadian DIN record